Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. R.A. (Robert) Schoevers

Publicaties

Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study

Change in brain activation after transcranial pulsed electromagnetic fields in treatment-resistant depression

Cognitive reactivity compared to other risk factors in the prediction of depressive episodes over two and nine years: a longitudinal cohort study

Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review

Development of a Cocreated Decision Aid for Patients With Depression-Combining Data-Driven Prediction With Patients' and Clinicians' Needs and Perspectives: Mixed Methods Study

Inpatient dialectical behavior therapy combined with trauma-focused therapy for PTSD and borderline personality disorder symptoms: study design of the naturalistic trauma therapy study

Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers

Oral Esketamine as Alternative for Maintenance Electroconvulsive Therapy in Patients with Treatment-Resistant Depression: A Case Series

Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program

Plasma esketamine and noresketamine levels and antidepressant response with oral esketamine treatment

Pers/media

Psychiater Robert Schoevers gaat op zoek naar betekenis

Farmaci psichedelici: al via il primo trial europeo sul distress nel fine vita

Wat hebben ketamine en depressie met elkaar te maken?

Trippend in de scanner: psilocybine heeft wekenlang effect op brein

UMCG neemt nieuw psychiatriegebouw in gebruik

UMCG heeft een nieuw, open en licht gebouw voor psychiatrie

‘MDMA en therapie mogelijk goed voor post-traumatische stress’

GGZ behandelplek van de toekomst – Channah Kruijt wint challenge